Ralph A. DeFronzo et al <br/><br/>
Safety and Tolerability of Combinations of Empagliflozin and Linagliptin in Patients with Type 2 Diabetes: Pooled Data from Two Randomized Controlled Trials 

<br/><br/><label>Subjects--Topical Terms: </label><br/>Computer science, information & general works